Camzyos’ failure in a form of hypertrophic cardiomyopathy dampened its commercial outlook and spurred debate as to whether ...

The American Heart Association recommends calling 911 if any of these symptoms develop, or if a person experiences a sudden loss of responsiveness or can't breathe normally, which are signs of cardiac ...

Bristol Myers Squibb stock skidded late Monday, tugging Cytokinetics lower, after Bristol's drug, Camzyos, failed in a heart disease study.

Bristol Myers Squibb's drug to treat a type of heart disease did not significantly improve functional capacity and symptoms ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.

April 8 on 39 types of medications, approximately a quarter of which are used to treat cardiovascular-related conditions. In ...

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later – can dramatically improve their outlook and even save lives. Patients trea ...

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...

A large European study has raised new concerns about a common medication used to treat high blood pressure. The drug, called ...